An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4404-4419

  Prasad, Alka ^a   Lu, Michael ^b   Lukac, David M ^c   Zeichner, Steven L ^a,d  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HOST CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; OPEN READING FRAME; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS REPLICATION;

APOPTOSIS; CASPASES; CELL LINE; ENZYME INHIBITORS; ETHANOLAMINES; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; KINETICS; MUTATION; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; VIRION; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8;

EID: 84861386828     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06617-11     Document Type: Article

References (53)

1. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-350.
2. Bais C, et al. 1998. G-protein-coupled receptor of Kaposi's sarcomaassociated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86-89.
3. Ballestas ME, Chatis PA, Kaye KM. 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641-644.
4. Boshoff C, et al. 1997. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278:290-295.
5. Bu W, Carroll KD, Palmeri D, Lukac DM. 2007. Kaposi's sarcomaassociated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer. J. Virol. 81:5788-5806.
6. Bu W, et al. 2008. Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization. J. Virol. 82:10709-10723.
7. Burysek L, et al. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 73:7334-7342.
8. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191.
9. Cesarman E, et al. 1996. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70:8218-8223.
10. Chang Y, et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
11. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. 2002. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432-1435.
12. Damania B. 2004. Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat. Rev. Microbiol. 2:656-668.
13. Guo HG, Pati S, Sadowska M, Charurat M, Reitz M. 2004. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J. Virol. 78:9336-9342.
14. Gwack Y, et al. 2003. Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation. Mol. Cell. Biol. 23:2055-2067.
15. Harrison SM, Whitehouse A. 2008. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter. FEBS Lett. 582:3080-3084.
16. Invitrogen Life Technologies Corporation. 2003. Flp-In T-REx core kit manual. Catalog number K6500-01. Invitrogen Life Technologies Corporation, Grand Island, NY.
17. Izumiya Y, et al. 2003. Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J. Virol. 77:1441-1451.
18. Kamada S, Kikkawa U, Tsujimoto Y, Hunter T. 2005. Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s). J. Biol. Chem. 280:857-860.
19. Kedes DH, Lagunoff M, Renne R, Ganem D. 1997. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Invest. 100:2606-2610.
20. Lamkanfi M, Dixit VM. 2010. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8:44-54.
21. Lan K, et al. 2005. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J. Virol. 79:7453-7465.
22. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D. 2002. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16:1977-1989.
23. Liang Y, Ganem D. 2004. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J. Virol. 78:6818-6826.
24. Liu J, Kuszynski CA, Baxter BT. 1999. Doxycycline induces Fas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes. Biochem. Biophys. Res. Commun. 260:562-567.
25. Lu M, et al. 2004. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir. J. Virol. 78:13637-13652.
26. Lukac DM, Garibyan L, Kirshner JR, Palmeri D, Ganem D. 2001. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J. Virol. 75:6786-6799.
27. Lukac DM, Kirshner JR, Ganem D. 1999. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73:9348-9361.
28. Moore P, Chang Y. 2001. Kaposi's sarcoma-associated herpesvirus, p 2803-2833. In Knipe D, Howley P, Griffin D, Lamb R, Martin M, Roizman B, Straus S (ed), Fields virology, 4th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
29. Moore PS, Boshoff C, Weiss RA, Chang Y. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739-1744.
30. Munger J, Hagglund R, Roizman B. 2003. Infected cell protein no. 22 is subject to proteolytic cleavage by caspases activated by a mutant that induces apoptosis. Virology 305:364-370.
31. Nakamura H, et al. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracyclineinducible Rta transactivator. J. Virol. 77:4205-4220.
32. Nicholas J, et al. 1997. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J. Virol. 71:1963-1974.
33. Nicholas J, et al. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin- Nat. Med. 3:287-292.
34. Paulose-Murphy M, et al. 2001. Transcription program of human her-pesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 75:4843-4853.
35. Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Chandran B. 2009. Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells. J. Virol. 83:4895-4911.
36. Renne R, et al. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346.
37. Russo JJ, et al. 1996. Nucleotide sequence of the Kaposi sarcomaassociated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U. S. A. 93:14862-14867.
38. Sakakibara S, Ueda K, Chen J, Okuno T, Yamanishi K. 2001. Octamerbinding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression. J. Virol. 75: 6894-6900.
39. Sarid R, Wiezorek JS, Moore PS, Chang Y. 1999. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J. Virol. 73:1438-1446.
40. Seaman WT, et al. 1999. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 263:436-449.
41. Slee EA, et al. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315(Part 1):21-24.
42. Soulier J, et al. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
43. Sun R, et al. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U. S. A. 95:10866-10871.
44. Sun R, et al. 1999. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73:2232-2242.
45. Wang S, Liu S, Wu M, Geng Y, Wood C. 2001. Kaposi's sarcomaassociated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence. Arch. Virol. 146:1415-1426.
46. Wang SE, et al. 2003. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP. J. Virol. 77:600-623.
47. Wang XP, et al. 2001. Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus. Oncogene 20:523-530.
48. Wang Y, Yuan Y. 2007. Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA. Virology 359:19-27.
49. West-Eberhard MJ. 2003. Developmental plasticity and evolution, 1st ed. Oxford University Press, New York, NY.
50. Wu L, et al. 2000. Three-dimensional structure of the human herpesvirus 8 capsid. J. Virol. 74:9646-9654.
51. Wu S, et al. 2004. Induction of apoptosis and down-regulation of Bcl-XL in cancer cells by a novel small molecule, 2[[3-(2,3-dichlorophenoxy) propyl]amino]ethanol. Cancer Res. 64:1110-1113.
52. Zhu FX, Cusano T, Yuan Y. 1999. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:5556-5567.
53. Zhu H, et al. 2004. Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK. Oncogene 23:4984-4992.